Johnson & Johnson
JNJ
#22
Rank
A$736.29 B
Marketcap
A$305.60
Share price
0.04%
Change (1 day)
35.60%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): A$16.35

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is A$15.61. In 2024 the company made an earnings per share (EPS) of A$10.01 a decrease over its 2023 EPS that were of A$21.56.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$16.3563.45%
2024A$10.01-53.6%
2023A$21.56111.16%
2022A$10.21-13.84%
2021A$11.8541.81%
2020A$8.36-18.92%
2019A$10.3121.2%
2018A$8.511125.3%
2017A$0.69-92.23%
2016A$8.937.37%
2015A$8.32-4.16%
2014A$8.6818.1%
2013A$7.3524.88%
2012A$5.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.57-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.35-27.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.00-29.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$5.54-64.50%๐Ÿ‡ซ๐Ÿ‡ท France
Stryker Corporation
SYK
A$11.53-26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$5.55-64.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$30.68 96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.05-22.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.38-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
A$9.75-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA